轮状病毒疫苗接种与儿童1型糖尿病无显著关联
这项回顾性队列研究纳入386 937名2006至2014年出生的儿童,随访至2017年底,比较轮状病毒疫苗全程暴露、部分暴露与未暴露儿童的1型糖尿病发病率。结果显示,与未暴露儿童相比,全程暴露的校正风险比为1.03(95% CI 0.62-1.72),部分暴露为1.50(95% CI 0.81-2.77),提示轮状病毒疫苗接种似乎与儿童1型糖尿病无关。
要点
- 全程接种轮状病毒疫苗与未接种相比,1型糖尿病风险无显著差异(校正HR 1.03,95% CI 0.62-1.72)。
- 部分接种的校正HR为1.50(95% CI 0.81-2.77),置信区间宽且包含1,无统计学显著性。
- 队列中1型糖尿病发病率为20.6例/10万人年,共464例。
核心结论
- 轮状病毒疫苗接种似乎与儿童1型糖尿病无关。
研究设计与样本
- 暴露定义为2至8月龄接种轮状病毒疫苗,分为全程暴露、部分暴露和未暴露三组。
主要发现
- 队列中93.1%儿童全程暴露,4.1%部分暴露,2.8%未暴露;中位随访5.4年(IQR 3.8-7.8),总随访2 253 879人年。
- 共发生464例1型糖尿病,发病率为20.6例/10万人年。
- 与未暴露儿童相比,全程暴露的校正风险比为1.03(95% CI 0.62-1.72),部分暴露为1.50(95% CI 0.81-2.77)。
临床怎么用
- 该研究结果支持轮状病毒疫苗接种不增加儿童1型糖尿病风险,可为疫苗接种咨询提供证据参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Because rotavirus infection is a hypothesized risk factor for type 1 diabetes, live attenuated rotavirus vaccination could increase or decrease the risk of type 1 diabetes in children. OBJECTIVE: To examine whether there is an association between rotavirus vaccination and incidence of type 1 diabetes in children aged 8 months to 11 years. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort study of 386 937 children born between January 1, 2006, and December 31, 2014, was conducted in 7 US health care organizations of the Vaccine Safety Datalink. Eligible children were followed up until a diagnosis of type 1 diabetes, disenrollment, or December 31, 2017. EXPOSURES: Rotavirus vaccination for children aged 2 to 8 months. Three exposure groups were created. The first group included children who received all recommended doses of rotavirus vaccine by 8 months of age (fully exposed to rotavirus vaccination). The second group had received some, but not all, recommended rotavirus vaccines (partially exposed to rotavirus vaccination). The third group did not receive any doses of rotavirus vaccines (unexposed to rotavirus vaccination). MAIN OUTCOMES AND MEASURES: Incidence of type 1 diabetes among children aged 8 months to 11 years. Type 1 diabetes was identified by International Classification of Diseases codes: 250.x1, 250.x3, or E10.xx in the outpatient setting. Cox proportional hazards regression models were used to analyze time to type 1 diabetes incidence from 8 months to 11 years. Hazard ratios and 95% CIs were calculated. Models were adjusted for sex, race/ethnicity, birth year, mother's age, birth weight, gestational age, number of well-child visits, and Vaccine Safety Datalink site. RESULTS: In a cohort of 386 937 children (51.1% boys and 41.9% non-Hispanic white), 360 169 (93.1%) were fully exposed to rotavirus vaccination, 15 765 (4.1%) were partially exposed to rotavirus vaccination, and 11 003 (2.8%) were unexposed to rotavirus vaccination. Children were followed up a median of 5.4 years (interquartile range, 3.8-7.8 years). The total person-time follow-up in the cohort was 2 253 879 years. There were 464 cases of type 1 diabetes in the cohort, with an incidence rate of 20.6 cases per 100 000 person-years. Compared with children unexposed to rotavirus vaccination, the adjusted hazard ratio was 1.03 (95% CI, 0.62-1.72) for children fully exposed to rotavirus vaccination and 1.50 (95% CI, 0.81-2.77) for children partially exposed to rotavirus vaccination. CONCLUSIONS AND RELEVANCE: The findings of this study suggest that rotavirus vaccination does not appear to be associated with type 1 diabetes in children.
引用
- Glanz JM, Clarke CL, Xu S, et al. Association Between Rotavirus Vaccination and Type 1 Diabetes in Children. JAMA Pediatr. 2020. PMID: 32150236. doi:10.1001/jamapediatrics.2019.6324
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。